Alkermes Plc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Alkermes Plc 's ROA in the second quarter of 2026?
Alkermes Plc achieved a return on average assets (ROA) of 1.97 % in its second quarter of 2026, this is above ALKS's average return on assets of -2.04%.
Alkermes Plc s assets during the 12 months ending in the second quarter of 2026 are valued at $3 billion

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 191 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 652 to 1105.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	95.01 %	105.79 %	21.85 %	12.46 %	6.2 %
Y / Y Net Income Change	-99.42 %	-	-66.32 %	-10.41 %	-4.66 %
Net Income (TTM) in million	66	153	242	339	348
Return On Assets (TTM)	1.97 %	5.42 %	10.66 %	15.69 %	16.63 %
ALKS's Total Ranking	# 1105	# 652	# 338	# 309	# 308
Total Assets (TTM) in million	4,393	4,284	2,404	2,330	2,253
Seq. Total Assets Change	2.54 %	78.21 %	3.2 %	3.4 %	8.21 %
Seq. Net Income Change	-	-	-40.38 %	-4.98 %	287.72 %

ALKS's 5 Years Annual ROA >> Back to ALKS Management Effectiveness >> Compare ALKS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 68
Sector	# 192
Overall	# 1835

Return On Assets Statistics
High	Average	Low
19.91 %	-2.04 %	-15.03 %
(Mar 31 2024)		(Jun 30 2016)

Financial Statements
Alkermes Plc 's Assets	$ 4,393 million	ALKS's Balance sheet
Alkermes Plc 's Income	$ 1 million	Quarterly ALKS's Income Statement
ALKS's Income by Division		See ALKS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	26.06 %	-3.68 %	10.67 %	-3.13 %	4.93 %
Total Assets in million	2,487	1,973	2,048	1,851	1,911
Y / Y Net Income Change	-34.16 %	3.18 %	-	-	-
Net Income in million	242	367	356	-158	-48
Annual Return On Assets	9.72 %	18.6 %	17.37 %	-8.55 %	-2.52 %

ALKS's 5 Years Annual ROA >> Back to ALKS Management Effectiveness >> Compare ALKS ROA to its Competitors

Comment on ALKS's ROA in the fiscal year ending 2025

In the fiscal year 2025 Alkermes Plc 's ROA decreased compared to previous year to 9.72 %, due to deterioration of net income -34.16 % to $241.66 million, from $367.07 million a year ago, as ALKS's assets were $2,487.14 million.

More Return On Assets Ratios
ALKS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ALKS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ALKS's Competitors
Subscribers only: Roa for Alkermes Plc 's Suppliers
Subscribers only: Return On Assets for ALKS's Customers

You may also want to know
ALKS's Roi	ALKS's Inventory Turnover Ratio	ALKS's Growth Rates	ALKS's Dividend Comparisons
	ALKS's Profitability Ratios	ALKS's Asset Turnover Ratio	ALKS's Dividend Growth
ALKS's Roe	ALKS's Valuation Ratios	ALKS's Financial Strength Ratios	ALKS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Labcorp Holdings Inc	5.40 %
Merit Medical Systems Inc	5.34 %
Sotera Health Company	5.03 %
Vericel Corporation	5.02 %
Kewaunee Scientific Corporation	4.96 %
Pacs Group Inc	4.78 %
Amphastar Pharmaceuticals Inc	4.70 %
Abbvie Inc	4.68 %
The Cooper Companies Inc	4.57 %
IMPACT BIOMEDICAL INC.	4.47 %
Nrc Health	4.31 %
Cadre Holdings inc	4.29 %
The Pennant Group Inc	4.14 %
U S Physical Therapy Inc	4.08 %
Haemonetics Corporation	3.99 %
Henry Schein Inc	3.79 %
Integer Holdings Corporation	3.76 %
Zimmer Biomet Holdings Inc	3.51 %
Ardent Health Inc	3.22 %
Community Health Systems Inc	3.17 %
Vaso Corporation	2.92 %
Collegium Pharmaceutical Inc	2.72 %
National Vision Holdings Inc	2.53 %
Conmed Corporation	2.44 %
Merck and Co Inc	2.42 %
Privia Health Group Inc	2.41 %
Lifestance Health Group Inc	2.33 %
Bio rad Laboratories Inc	2.21 %
Pfizer Inc	2.12 %
Mimedx Group Inc	1.99 %

Date modified: 2026-07-29T06:45:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.